Finnish investor looks for Nordic investors in its new life science & health fund

Two Finnish foundations are among the seed investors of a new life science fund that aims to return at least 250 percent. ”We will now start negotiations with international investors,” says Pekka Simula, partner at Innovestor. The new fund’s management team hopes to replicate what other Nordic life science funds have achieved.

Minna Koistinaho and Pekka Simula, partners at Innovestor | Photo: Innovestor PR.

Finnish venture capital firm Innovestor has launched a new life science and health fund focusing on early stage opportunities in the Nordic and Baltic countries.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs